The Nifty Pharma index closed on a negative note on Wednesday. Shares of Mankind Pharma Ltd.(up 0.24 per cent), Biocon ...

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...

AM(IST)on Monday in an upbeat market. Gland Pharma Ltd.(up 2.26 per cent), Laurus Labs Ltd.(up 2.02 per cent), J B Chemicals ...

Vahdam Teas, which primarily generates revenue internationally, is prioritizing product development over café expansion, ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

The event saw the unveiling of BT India’s Best CEOs Awards 2025—a high-powered list of winners celebrating business ...

The share sale, which is expected to take place at a valuation of around $5 billion, is part of its strategy increase Indian ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Gas companies are in focus on Monday, following proposed regulatory changes for long-haul natural gas transportation tariff ...

Barclays has been actively participating in private credit transactions, including its recent involvement in financing the ...